Awad, M., Singh, P., & Hilas, O. (2017). Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA. P T.
Chicago Style aipamenaAwad, Mina, Pavit Singh, and Olga Hilas. "Zarxio (Filgrastim-sndz): The First Biosimilar Approved By the FDA." P T 2017.
MLA aipamenaAwad, Mina, Pavit Singh, and Olga Hilas. "Zarxio (Filgrastim-sndz): The First Biosimilar Approved By the FDA." P T 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.